Bacterial lipoproteins have attracted much interest as vaccine candidates over recent years. The lipoprotein, Factor H binding protein, of Neisseria meningitidis for example is the sole antigen of Trumenba, the vaccine developed by Pfizer, and is a major component of the Bexsero vaccine developed by GSK.
Read more